Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
Modular Medical (NASDAQ:MODD) announced that the first patients have completed training and started using its Pivot™ tubeless insulin patch pump in real-world settings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Modular Medical (NASDAQ:MODD) announced that the first patients have completed training and started using its Pivot™ tubeless insulin patch pump in real-world settings. This marks the transition from development to active patient use and advances its commercialization strategy.
Pivot is described as the first insulin pump specifically designed for the large, underserved population of insulin-dependent adults still using multiple daily injections, a multibillion-dollar market. Modular Medical plans to collect real-world utilization data and user feedback to support broader adoption and optimize product deployment.
Positive
- First patients now using Pivot tubeless insulin patch pump in real-world settings
- Pivot moves from development stage into active patient use
- Event advances Modular Medical's commercialization strategy for Pivot
- Targeting a multibillion-dollar market of adults on multiple daily injections
- Plan to collect real-world utilization data and feedback to refine deployment
Negative
- None.
Details
News Market Reaction – MODD
On Jun 30, the day this news came out, MODD closed 7.79% below the previous close.
Data tracked by StockTitan Argus for the Jun 30 session.
Historical Context
-
Announced Pivot starter kits shipping to endocrinology practices for training.
-
Announced U.S. commercial availability of Pivot tubeless insulin patch pump.
-
Launched PivotPump.com to support patients exploring insulin pump therapy.
-
Announced CEO webinar on FDA wins and scaling manufacturing.
-
Priced $3.4M registered direct offering of common stock under S-3 shelf.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
tubeless insulin patch pump medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial Company
Pivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent Adults Still Relying on Multiple Daily Injections, a Multibillion-Dollar Market
SAN DIEGO, CO / ACCESS Newswire / June 30, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced that the first patients have completed onboarding and training and are now actively using the Pivot™ tubeless insulin patch pump in real-world settings.
This milestone marks the transition of the Pivot pump from development into active patient use and represents a significant step in Modular Medical's commercialization strategy. The Company will now begin collecting real world utilization data and user feedback to support broader adoption and continued product deployment optimization.
"Today represents a defining moment for Modular Medical," said Jeb Besser, Chief Executive Officer of Modular Medical. "For the first time, patients are using Pivot to manage their insulin therapy, validating our vision of creating a simpler, more accessible pump solution for people who have historically remained on multiple daily injections. This is only the beginning of our efforts to address this substantial market opportunity, and we look forward to gathering real-world data and feedback, as we seek to scale adoption and achieve long-term growth."
For more information on the Pivot system, visit the dedicated site: PivotPump.com and YouTube Pivot Insulin Delivery System channel searchable @ModularMedical.
About Modular Medical
Modular Medical, Inc. (NASDAQ:MODD) is a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
Pivot is a trademark of Modular Medical in the United States. All other trademarks mentioned herein are the property of their respective owners.
Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statements contained in this press release, including but not limited to, the Company's ability to convert patients to use its Pivot pump product; successful development of Modular Medical's proprietary technologies, whether the market will accept Modular Medical's products and services, anticipated consumer demand for the Company's products, whether Modular Medical can successfully manufacture its products at high volumes, general economic, and industry or political conditions in the United States or internationally, as well as other risk factors and business considerations described in Modular Medical's SEC filings, including its annual report on Form 10-K. Any forward-looking statements in this press release should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent Modular Medical's views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. Modular Medical assumes no obligation to update these forward-looking statements, except as required by law.
Company Contact:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
IR@modular-medical.com
Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
ModularMedical@KSCA.com
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.